KVK-Tech, Inc. (KVK) and its affiliate Penn Life Sciences, Inc. (PLS) have announced that they have appointed Ram Kamineni as Chief Operating Officer, effective April 8, 2021.
Kamineni brings more than 38 years of pharma industry experience to the company. He most recently served as the SVP, Head of Global Operations for Jubilant Pharma. Prior to that, he served as VP, Head of Global OSD Manufacturing Strategy for Mylan. He also had several roles including Novartis, Patheon, and Merck Generics.
Kamineni will bring his diverse experience which includes: manufacturing and packaging of oral solids and liquids, sterile injectables (Liquid, Lyo, PFS, ampoules etc.,) transdermal formulations, respiratory dosage forms (pMDIs, DPIs and nebules), Radio Pharmaceuticals and API manufacturing.
KVK and PLS CEO, Anthony Tabasso said, “We are extremely pleased and excited to welcome Ram as our Chief Operating Officer. With his unique experience and hands-on leadership philosophy, he is an excellent fit. We are confident Ram’s knowledge and expertise will further advance our goal to establish our company as a leader in the generics industry. I look forward to working closely with him as we build on our strong foundation to drive sustainable growth, with an emphasis on quality and compliance.”
Kamineni said, “With its exciting goals and compelling strategy, I believe KVK and PLS are well-positioned for generational success.”
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.